Status | Study |
Recruiting |
Study Name: Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia Condition: Congenital Adrenal Hyperplasia Date: 2016-02-26 Interventions: Drug: Chronocort® Chronoc |
Not yet recruiting |
Study Name: Dynamic Hormone Diagnostics in Endocrine Disease Condition: Adrenal Insufficiency Congenital Adrenal Hyperplasia Date: 2016-01-12 Interventions: Other: 27 hour subcutaneous fluid sampling One hour prior |
Recruiting |
Study Name: Acupuncture or Metformin for Insulin Resistance in Women With PCOS Condition: Polycystic Ovary Syndrome Insulin Resistance Hyperandrogen Date: 2015-12-23 Interventions: Other: Lifestyle management Al |
Completed |
Study Name: Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women Condition: Polycystic Ovary Syndrome Menstrual Pattern Hyperandrogeni Date: 2015-11-27 Interventions: Drug: myo-inositol,alpha-lipoic acid and folic acid |
Recruiting |
Study Name: Urinary DENND1A.V2 as a Predictor of Pubertal Hyperandrogenemia Condition: Polycystic Ovary Syndrome Hyperandrogenism Puberty Date: 2015-11-12 Interventions: Other: Phenotype/genotype assessment The investigators will perform careful phenotyping in addition to h |
Recruiting |
Study Name: COrticosteroid in Congenital Adrenal Hyperplasia Condition: Congenital Adrenal Hyperplasia Date: 2015-07-27 Interventions: Biological: Hormonal balance measurements |
Enrolling by invitation |
Study Name: Metformine and CC Compared With Placebo and CC for Induction Ovulation in PCOS Patients With Insulin Resistant Condition: Polycystic Ovary Syndrome Hyperandrogenism Date: 2015-07-11 Interventions: Drug: metformine 1500 mg metfo |
Recruiting |
Study Name: Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome Condition: Cushing's Syndrome Ectopic Corticotropin Syndrome Adrenal Date: 2015-06-08 Interventions: Drug: Osilodrostat Osilodrostat will be prescribed by the investigator. Osirodrostat 1 mg, 5 mg, 10 mg, |
Recruiting |
Study Name: Phlebotomy and Polycystic Ovary Syndrome Condition: Hyperandrogenism Metabolic Cardiovascular Syndrome Date: 2015-05-27 Interventions: Procedure: Phlebotomy Schedule |
Not yet recruiting |
Study Name: Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 Condition: Congenital Adrenal Hyperplasia Date: 2015-04-24 Interventions: Drug: Abiraterone acetate This is a dose escalation study. Up to 3 successive cohorts of 8 subjects each |